Parker H J, Fell G, Devine T J, King R B
Western General Hospital Vascular Unit, Melbourne, Australia.
J Cardiovasc Surg (Torino). 1988 Nov-Dec;29(6):727-32.
This study is based on 223 consecutive femoro-popliteal and femorotibial bypass grafts performed between January 1978 and June 1985 at the Western General Hospital. Autogenous vein grafts demonstrated better 5 year patency rates (54%) than modified human umbilical vein (32%). The superiority of autogenous vein was even more marked when anastomoses were to below knee vessels: 56% compared with 26% at 5 years. Grafts anastomosed to the superficial femoral artery had similar long term patency to those anastomosed to the common femoral artery. When grafts were required for severe ischaemia, similar 5 year patency rates were achieved with autogenous vein (35%) and modified human umbilical vein (30%). The 5 year limb salvage rate in severe ischaemia was 72% for autogenous vein and 63% for modified human umbilical vein. The findings confirm that modified human umbilical vein is a satisfactory alternative when autogenous vein is not available.
本研究基于1978年1月至1985年6月在西部总医院连续进行的223例股腘和股胫旁路移植手术。自体静脉移植物的5年通畅率(54%)高于改良人脐静脉(32%)。当吻合至膝下血管时,自体静脉的优势更为明显:5年时分别为56%和26%。吻合至股浅动脉的移植物与吻合至股总动脉的移植物长期通畅率相似。当严重缺血需要进行移植物手术时,自体静脉(35%)和改良人脐静脉(30%)的5年通畅率相似。严重缺血时,自体静脉的5年肢体挽救率为72%,改良人脐静脉为63%。这些发现证实,在无法获得自体静脉时,改良人脐静脉是一种令人满意的替代选择。